valsartan (Diovan) improves survival after a heart attack

December 2003

There's now evidence that valsartan (Diovan) improves survival after a heart attack. It's the first angiotensin receptor blocker to show this benefit.

Most patients get an ACE inhibitor after an MI...along with aspirin, a statin, and a beta-blocker.

But valsartan seems to work as well as an ACE inhibitor for improving survival and preventing recurrent MIs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote